FAK signaling in human cancer as a target for therapeutics.

[1]  Xiangfan Liu,et al.  New Insights into FAK Phosphorylation Based on a FAT Domain-Defective Mutation , 2014, PloS one.

[2]  D. Schlaepfer,et al.  FAK in cancer: mechanistic findings and clinical applications , 2014, Nature Reviews Cancer.

[3]  J. Gribben,et al.  Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy , 2014, Nature.

[4]  Francesco Luigi Gervasio,et al.  Phosphatidylinositol 4,5-bisphosphate triggers activation of focal adhesion kinase by inducing clustering and conformational changes , 2014, Proceedings of the National Academy of Sciences.

[5]  D. Schlaepfer,et al.  Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer. , 2014, Gynecologic oncology.

[6]  Andrea I. McClatchey,et al.  Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship , 2014, Science Translational Medicine.

[7]  Xin Hu,et al.  An aberrant spliced transcript of focal adhesion kinase is exclusively expressed in human breast cancer , 2014, Journal of Translational Medicine.

[8]  B. van de Water,et al.  Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation , 2014, British Journal of Cancer.

[9]  K. Baggerly,et al.  Focal adhesion kinase , 2014, Cancer biology & therapy.

[10]  N. Carragher,et al.  Developments in preclinical cancer imaging: innovating the discovery of therapeutics , 2014, Nature Reviews Cancer.

[11]  G. Elia,et al.  Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer , 2014, BMC Cancer.

[12]  Jean-Antoine Girault,et al.  FAK dimerization controls its kinase‐dependent functions at focal adhesions , 2014, The EMBO journal.

[13]  Jiangwen Zhang,et al.  Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia , 2014, Nature Immunology.

[14]  E. Dejana,et al.  Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function , 2014, The Journal of cell biology.

[15]  Xu-Qian Fang,et al.  Somatic mutational analysis of FAK in breast cancer: a novel gain-of-function mutation due to deletion of exon 33. , 2014, Biochemical and biophysical research communications.

[16]  M. Rubin,et al.  Somatic copy number alterations by whole‐exome sequencing implicates YWHAZ and PTK2 in castration‐resistant prostate cancer , 2013, The Journal of pathology.

[17]  Jianmin Wu,et al.  Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer , 2013, Molecular Cancer Therapeutics.

[18]  D. Schlaepfer,et al.  A non-canonical role for Rgnef in promoting integrin-stimulated focal adhesion kinase activation , 2013, Journal of Cell Science.

[19]  Jie Huang,et al.  Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. , 2013, Journal of the National Cancer Institute.

[20]  D. Barber,et al.  pH sensing by FAK-His58 regulates focal adhesion remodeling , 2013, The Journal of cell biology.

[21]  M. Wicha,et al.  Distinct FAK activities determine progenitor and mammary stem cell characteristics. , 2013, Cancer research.

[22]  A. Magis,et al.  Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth , 2013, BMC Cancer.

[23]  V. Golubovskaya,et al.  Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy , 2013, Cancer biology & therapy.

[24]  D. Tarin,et al.  Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression , 2013, Clinical & Experimental Metastasis.

[25]  M. Parsons,et al.  FAK-heterozygous mice display enhanced tumour angiogenesis , 2013, Nature Communications.

[26]  A. Magis,et al.  A small-molecule inhibitor, 5'-O-tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo. , 2013, Anti-cancer agents in medicinal chemistry.

[27]  A. Magis,et al.  Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo. , 2013, Anti-cancer agents in medicinal chemistry.

[28]  M. Rivera,et al.  High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma. , 2013, Cancer research.

[29]  V. Golubovskaya,et al.  Disrupting the Scaffold to Improve Focal Adhesion Kinase–Targeted Cancer Therapeutics , 2013, Science Signaling.

[30]  P. Timpson,et al.  Loss of Scar/WAVE Complex Promotes N-WASP- and FAK-Dependent Invasion , 2013, Current Biology.

[31]  J. Guan,et al.  Function of Focal Adhesion Kinase Scaffolding to Mediate Endophilin A2 Phosphorylation Promotes Epithelial-Mesenchymal Transition and Mammary Cancer Stem Cell Activities in Vivo* , 2012, The Journal of Biological Chemistry.

[32]  C. Morrison,et al.  Pharmacologic Blockade of FAK Autophosphorylation Decreases Human Glioblastoma Tumor Growth and Synergizes with Temozolomide , 2012, Molecular Cancer Therapeutics.

[33]  Owen J Sansom,et al.  Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. , 2012, Carcinogenesis.

[34]  D. Chung,et al.  FAK is a Critical Regulator of Neuroblastoma Liver Metastasis , 2012, Oncotarget.

[35]  S. Hatakeyama,et al.  Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma. , 2012, Oral oncology.

[36]  J. Asara,et al.  Protein Tyrosine Kinase 6 Protects Cells from Anoikis by Directly Phosphorylating Focal Adhesion Kinase and Activating AKT , 2012, Oncogene.

[37]  S. Sebti,et al.  Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth , 2012, Cell cycle.

[38]  S. Wilkinson,et al.  Src‐dependent autophagic degradation of Ret in FAK‐signalling‐defective cancer cells , 2012, EMBO reports.

[39]  V. Brunton,et al.  The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells , 2012, International journal of cancer.

[40]  B. Al-Lazikani,et al.  Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.

[41]  R. Plummer,et al.  Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors. , 2012 .

[42]  D. Camidge,et al.  Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  W. Muller,et al.  Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo , 2012, Breast Cancer Research.

[44]  M. McNiven,et al.  Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK–p130Cas complex , 2012, The Journal of cell biology.

[45]  S. Lim,et al.  FAK promotes recruitment of talin to nascent adhesions to control cell motility , 2012, The Journal of cell biology.

[46]  J. Guan,et al.  VEGF-induced vascular permeability is mediated by FAK. , 2012, Developmental cell.

[47]  O. Sansom,et al.  FAK Deletion Promotes p53-Mediated Induction of p21, DNA-Damage Responses and Radio-Resistance in Advanced Squamous Cancer Cells , 2011, PloS one.

[48]  Owen J. Sansom,et al.  Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling , 2011, Nature Cell Biology.

[49]  M. Schleicher,et al.  Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer. , 2011 .

[50]  C. Knapp,et al.  Antibiotic Resistance Gene Abundances Correlate with Metal and Geochemical Conditions in Archived Scottish Soils , 2011, PloS one.

[51]  A. Sood,et al.  Enhancing anti-angiogenic therapy by blocking focal adhesion kinase , 2011 .

[52]  J. Parsons,et al.  Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment , 2011, Molecular Cancer Therapeutics.

[53]  D. Noh,et al.  Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer , 2011, Breast Cancer Research and Treatment.

[54]  S. Chien,et al.  Detection of focal adhesion kinase activation at membrane microdomains by fluorescence resonance energy transfer. , 2011, Nature communications.

[55]  Hans Clevers,et al.  Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth. , 2024, Cancer cell.

[56]  M. Fresno,et al.  Cortactin and Focal Adhesion Kinase as Predictors of Cancer Risk in Patients with Laryngeal Premalignancy , 2011, Cancer Prevention Research.

[57]  G. Shapiro,et al.  Phase I study of PF-04554878, a second-generation focal adhesion kinase (FAK) inhibitor, in patients with advanced solid tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  S. Hatakeyama,et al.  Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. , 2011, Experimental cell research.

[59]  A. Sood,et al.  Abstract LB-230: Enhancing anti-angiogenic therapy by blocking focal adhesion kinase , 2011 .

[60]  P. Chan,et al.  Phosphorylation of focal adhesion kinase on tyrosine 194 by Met leads to its activation through relief of autoinhibition , 2011, Oncogene.

[61]  M. Frame,et al.  Signaling of the direction-sensing FAK/RACK1/PDE4D5 complex to the small GTPase Rap1 , 2011, Small GTPases.

[62]  M. Parsons,et al.  Endothelial FAK is required for tumour angiogenesis , 2010, EMBO molecular medicine.

[63]  W. Kim,et al.  Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. , 2010, Human pathology.

[64]  P. Timpson,et al.  Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. , 2010, Cancer research.

[65]  David R. Croucher,et al.  Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. , 2010, Cancer research.

[66]  M. Eck,et al.  The FERM domain: organizing the structure and function of FAK , 2010, Nature Reviews Molecular Cell Biology.

[67]  Julie A. Wilkins,et al.  Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. , 2010, Developmental cell.

[68]  E. Gardner,et al.  Bioluminescent imaging study , 2010, Cancer biology & therapy.

[69]  Houjie Liang,et al.  The effect of focal adhesion kinase gene silencing on 5‐fluorouracil chemosensitivity involves an Akt/NF‐κB signaling pathway in colorectal carcinomas , 2010, International journal of cancer.

[70]  G. Mcmahon,et al.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models , 2010, Cancer biology & therapy.

[71]  G. Mcmahon,et al.  PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments , 2010, Cancer biology & therapy.

[72]  W. Fiedler,et al.  Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer , 2010, Expert opinion on investigational drugs.

[73]  Liz Y. Han,et al.  Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. , 2010, The Journal of clinical investigation.

[74]  Michael D Schaller,et al.  Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.

[75]  Semi Kim,et al.  TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. , 2010, Carcinogenesis.

[76]  B. O’Malley,et al.  SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration. , 2010, Molecular cell.

[77]  A. Huttenlocher,et al.  Regulation of Adhesion Dynamics by Calpain-mediated Proteolysis of Focal Adhesion Kinase (FAK)* , 2010, The Journal of Biological Chemistry.

[78]  Paul Timpson,et al.  Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.

[79]  E. Hurt,et al.  Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation , 2009, Stem cells.

[80]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[81]  C. Turner,et al.  Paxillin-kinase-linker Tyrosine Phosphorylation Regulates Directional Cell Migration Directed Cell Migration Requires the Coordination of Growth Factor and Cell Adhesion Signaling and Is of Fundamental Importance during Embryonic Development, Wound Repair, and Pathological Conditions Such as Tumor M , 2022 .

[82]  V. Golubovskaya,et al.  A novel strategy to inhibit FAK and IGF‐1R decreases growth of pancreatic cancer xenografts , 2009, Molecular carcinogenesis.

[83]  D. Schlaepfer,et al.  Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. , 2009, Current opinion in cell biology.

[84]  R. Millikan,et al.  FAK overexpression and p53 mutations are highly correlated in human breast cancer , 2009, International journal of cancer.

[85]  Houjie Liang,et al.  Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance , 2009, Cancer science.

[86]  A. Magis,et al.  Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo. , 2009, Journal of medicinal chemistry.

[87]  J. Klijanienko,et al.  Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[88]  A. Magis,et al.  A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer , 2009, Cell cycle.

[89]  J. Bai,et al.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion , 2009, British Journal of Cancer.

[90]  S. Lim,et al.  A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells , 2009, Journal of Cell Science.

[91]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[92]  T. Tuthill,et al.  Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model , 2009, Cancer biology & therapy.

[93]  M. Bogyo,et al.  Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. , 2009, Cancer research.

[94]  Neil O Carragher,et al.  Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development. , 2009, Cancer research.

[95]  W. Gerald,et al.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.

[96]  C. Turner,et al.  FAK engages multiple pathways to maintain survival of fibroblasts and epithelia – differential roles for paxillin and p130Cas , 2009, Journal of Cell Science.

[97]  M. Wicha,et al.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. , 2009, Cancer research.

[98]  S. Hirota,et al.  Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor , 2009, Molecular Cancer Therapeutics.

[99]  T. Kasahara,et al.  Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. , 2008, Cancer letters.

[100]  Paolo P. Provenzano,et al.  Tumorigenesis and Neoplastic Progression Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer , 2008 .

[101]  K. Francis,et al.  Formation of Kv2.1‐FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility , 2008, Journal of cellular physiology.

[102]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[103]  S. Lim,et al.  FERM control of FAK function: Implications for cancer therapy , 2008, Cell cycle.

[104]  D. Beer,et al.  Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo , 2008, Clinical Cancer Research.

[105]  V. Golubovskaya,et al.  FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. , 2008, Carcinogenesis.

[106]  C. Bagi,et al.  Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors , 2008, Cancer.

[107]  G. Kouraklis,et al.  Clinical significance of FAK expression in human neoplasia. , 2008, Histology and histopathology.

[108]  V. Golubovskaya,et al.  p53 regulates FAK expression in human tumor cells , 2008, Molecular carcinogenesis.

[109]  J. Parsons,et al.  FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts , 2008, Journal of Cell Science.

[110]  Matthew D. Wessel,et al.  Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.

[111]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[112]  Susan J Fisher,et al.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.

[113]  M. Gardel,et al.  PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility , 2008, The Journal of cell biology.

[114]  Zenon Rajfur,et al.  Multiple paxillin binding sites regulate FAK function , 2008, Journal of molecular signaling.

[115]  V. Golubovskaya,et al.  TAE226 Inhibits Human Neuroblastoma Cell Survival , 2008, Cancer investigation.

[116]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[117]  Liz Y. Han,et al.  Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. , 2007, Cancer research.

[118]  Ken Jacobson,et al.  Spatial and Temporal Regulation of Focal Adhesion Kinase Activity in Living Cells , 2007, Molecular and Cellular Biology.

[119]  C. Pilarsky,et al.  Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1 , 2007, Oncogene.

[120]  Y. Kapila,et al.  An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK , 2007, Apoptosis.

[121]  Gareth E. Jones,et al.  Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex , 2007, Nature Cell Biology.

[122]  T. Tsuruo,et al.  Fak/Src signaling in human intestinal epithelial cell survival and anoikis: Differentiation state‐specific uncoupling with the PI3‐K/Akt‐1 and MEK/Erk pathways , 2007, Journal of cellular physiology.

[123]  P. Bonnier,et al.  Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. , 2007, International journal of oncology.

[124]  M. Chou,et al.  Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer. , 2007, Oncology reports.

[125]  Xinming Cai,et al.  Structural Basis for the Autoinhibition of Focal Adhesion Kinase , 2007, Cell.

[126]  Osamu Ohmori,et al.  A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth , 2007, Molecular carcinogenesis.

[127]  Christopher Autry,et al.  Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.

[128]  Y. Sonoda,et al.  Focal adhesion kinase determines the fate of death or survival of cells in response to TNFalpha in the presence of actinomycin D. , 2007, Biochimica et biophysica acta.

[129]  W. Yung,et al.  Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[130]  David S. Rogers,et al.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.

[131]  Y. Takata,et al.  Focal adhesion kinase mediates cell survival via NF-κB and ERK signaling pathways , 2007 .

[132]  J. Rodrigo,et al.  Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. , 2007, Archives of otolaryngology--head & neck surgery.

[133]  Xian-feng Zhang,et al.  Enhanced expression of cholecystokinin‐2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase , 2006, International journal of cancer.

[134]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[135]  D. A. Hanson,et al.  Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors , 2006, Oncogene.

[136]  Alfredo Gorio,et al.  Up-regulation of focal adhesion kinase in non-small cell lung cancer. , 2006, Lung cancer.

[137]  Sami Alom Ruiz,et al.  An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling , 2006, The Journal of cell biology.

[138]  Shu-yi Chen,et al.  Direct Interaction of Focal Adhesion Kinase (FAK) with Met Is Required for FAK To Promote Hepatocyte Growth Factor-Induced Cell Invasion , 2006, Molecular and Cellular Biology.

[139]  C. Waterman-Storer,et al.  Spatiotemporal Feedback between Actomyosin and Focal-Adhesion Systems Optimizes Rapid Cell Migration , 2006, Cell.

[140]  A. Herrero,et al.  Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number , 2006, Clinical Cancer Research.

[141]  E. Stickeler,et al.  Weak Expression of Focal Adhesion Kinase (pp125FAK) in Patients with Cervical Cancer Is Associated with Poor Disease Outcome , 2006, Clinical Cancer Research.

[142]  Zhiqiang Li,et al.  Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells , 2006, Journal of Neuro-Oncology.

[143]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[144]  V. Golubovskaya,et al.  Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. , 2006, Cancer research.

[145]  D. Ito,et al.  Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer , 2006, World Journal of Surgery.

[146]  A. Sood,et al.  Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells , 2005, Clinical Cancer Research.

[147]  M. Hendrix,et al.  Focal adhesion kinase promotes the aggressive melanoma phenotype. , 2005, Cancer research.

[148]  E. Avizienyte,et al.  Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. , 2005, Current opinion in cell biology.

[149]  Joseph Geradts,et al.  High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.

[150]  Anna Huttenlocher,et al.  Regulating cell migration: calpains make the cut , 2005, Journal of Cell Science.

[151]  R. Juliano,et al.  Clinging to life: cell to matrix adhesion and cell survival , 2005, Cancer and Metastasis Reviews.

[152]  J. Guan,et al.  FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. , 2005, Developmental cell.

[153]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[154]  V. Golubovskaya,et al.  Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53* , 2005, Journal of Biological Chemistry.

[155]  J. Parsons,et al.  Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells , 2005, Journal of Cell Science.

[156]  Lung-Ta Lee,et al.  Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. , 2005, Anticancer research.

[157]  J. Guan,et al.  p27Kip1 and Cyclin D1 Are Necessary for Focal Adhesion Kinase Regulation of Cell Cycle Progression in Glioblastoma Cells Propagated in Vitro and in Vivo in the Scid Mouse Brain* , 2005, Journal of Biological Chemistry.

[158]  David A Foster,et al.  Alternative phospholipase D/mTOR survival signal in human breast cancer cells , 2005, Oncogene.

[159]  S. Grant,et al.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.

[160]  C. Livasy,et al.  Focal Adhesion Kinase Overexpression in Endometrial Neoplasia , 2004, Applied immunohistochemistry & molecular morphology : AIMM.

[161]  Michael D Schaller,et al.  The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.

[162]  Anil K Sood,et al.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. , 2004, The American journal of pathology.

[163]  J. Mok,et al.  Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study , 2004, Journal of Korean medical science.

[164]  R. Klemke,et al.  Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold. , 2004, Biochimica et biophysica acta.

[165]  T. Fujii,et al.  Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. , 2004, Journal of hepatology.

[166]  V. Golubovskaya,et al.  Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. , 2004, Biochimica et biophysica acta.

[167]  K. Hahn,et al.  Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility , 2004, The Journal of cell biology.

[168]  S. Hanks,et al.  Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor-Interacting Protein , 2004, Molecular and Cellular Biology.

[169]  S. Ashley,et al.  Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. , 2004, Surgery.

[170]  S. Lowe,et al.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.

[171]  T. Takenawa,et al.  Focal Adhesion Kinase Regulation of N-WASP Subcellular Localization and Function* , 2004, Journal of Biological Chemistry.

[172]  Donna J. Webb,et al.  FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly , 2004, Nature Cell Biology.

[173]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[174]  M. Schaller,et al.  FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.

[175]  S. Ashley,et al.  RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. , 2003, Biochemical and biophysical research communications.

[176]  J. Inazawa,et al.  PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas , 2003, Hepatology.

[177]  Neil O. Carragher,et al.  A Novel Role for FAK as a Protease-Targeting Adaptor Protein Regulation by p42 ERK and Src , 2003, Current Biology.

[178]  D. Schlaepfer,et al.  Direct Interaction of Focal Adhesion Kinase with p190RhoGEF* , 2003, Journal of Biological Chemistry.

[179]  H. Kuwano,et al.  FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[180]  S. Hanks,et al.  Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. , 2003, Frontiers in bioscience : a journal and virtual library.

[181]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[182]  J. Parsons,et al.  Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.

[183]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[184]  G. Nemerow,et al.  Differential regulation of cell motility and invasion by FAK , 2003, The Journal of cell biology.

[185]  L. Koss,et al.  Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. , 2003, Human pathology.

[186]  C. Damsky,et al.  Focal Adhesion Kinase Is Required for Blood Vessel Morphogenesis , 2003, Circulation research.

[187]  X. Si,et al.  PTPα regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration , 2003, The Journal of cell biology.

[188]  M. Hendrix,et al.  Elevated focal adhesion kinase expression facilitates oral tumor cell invasion , 2002, Cancer.

[189]  D. Schlaepfer,et al.  FRNK blocks v‐Src‐stimulated invasion and experimental metastases without effects on cell motility or growth , 2002, The EMBO journal.

[190]  H. Hanafusa,et al.  v-Crk Activates the Phosphoinositide 3-Kinase/AKT Pathway by Utilizing Focal Adhesion Kinase and H-Ras , 2002, Molecular and Cellular Biology.

[191]  Hiroki Ueda,et al.  Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. , 2002, Molecular biology of the cell.

[192]  J. Su,et al.  Expression of focal adhesion kinase and α5 and β1 integrins in carcinomas and its clinical significance , 2002 .

[193]  G. McLean,et al.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling , 2002, Nature Cell Biology.

[194]  Gerald R. Fink,et al.  Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex , 2002, Nature Cell Biology.

[195]  C. Thompson,et al.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. , 2002, Molecular biology of the cell.

[196]  A. Karginov,et al.  The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. , 2002, Molecular biology of the cell.

[197]  D. Schlaepfer,et al.  v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.

[198]  D. Sheppard,et al.  Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling , 2002, The Journal of cell biology.

[199]  J. Guan,et al.  Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. , 2001, Molecular biology of the cell.

[200]  P. Timpson,et al.  Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity , 2001, Current Biology.

[201]  J. Girault,et al.  Ezrin Interacts with Focal Adhesion Kinase and Induces Its Activation Independently of Cell-matrix Adhesion* , 2001, The Journal of Biological Chemistry.

[202]  D. Schlaepfer,et al.  Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.

[203]  A. Merlo,et al.  PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). , 2001, Cancer research.

[204]  A. Merlo,et al.  Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. , 2001, Cancer research.

[205]  J. Guan,et al.  Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts , 2001, FEBS letters.

[206]  E. Rozengurt,et al.  Src Family Kinases Are Required for Integrin-mediated but Not for G Protein-coupled Receptor Stimulation of Focal Adhesion Kinase Autophosphorylation at Tyr-397* , 2001, The Journal of Biological Chemistry.

[207]  H. Kung,et al.  Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain , 2001, Nature Cell Biology.

[208]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[209]  L. Mei,et al.  Regulation of Cdc42 Gtpase by Proline-Rich Tyrosine Kinase 2 Interacting with Psgap, a Novel Pleckstrin Homology and Src Homology 3 Domain Containing Rhogap Protein , 2001, The Journal of cell biology.

[210]  J. Parsons,et al.  Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells , 2001, Molecular and Cellular Biology.

[211]  I. Zachary,et al.  Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. , 2000, Biochemical and biophysical research communications.

[212]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[213]  S. Hanks,et al.  Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.

[214]  C. Damsky,et al.  Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. , 2000 .

[215]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[216]  L. Romer,et al.  Integrin-Mediated Survival Signals Regulate the Apoptotic Function of Bax through Its Conformation and Subcellular Localization , 2000, The Journal of cell biology.

[217]  Jonathan A. Cooper,et al.  The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[218]  M. Kinch,et al.  Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation , 2000, Nature Cell Biology.

[219]  T. Veikkola,et al.  Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.

[220]  Xiaping He,et al.  Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma , 1999, Cancer.

[221]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[222]  M. Tang,et al.  Suppression of Ultraviolet Irradiation-induced Apoptosis by Overexpression of Focal Adhesion Kinase in Madin-Darby Canine Kidney Cells* , 1999, The Journal of Biological Chemistry.

[223]  D. Schlaepfer,et al.  Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.

[224]  R. Birge,et al.  Integrin-mediated Activation of Focal Adhesion Kinase Is Required for Signaling to Jun NH2-terminal Kinase and Progression through the G1 Phase of the Cell Cycle , 1999, The Journal of cell biology.

[225]  C. Parent,et al.  A cell's sense of direction. , 1999, Science.

[226]  Shiro Watanabe,et al.  FAK Is the Upstream Signal Protein of the Phosphatidylinositol 3-Kinase-Akt Survival Pathway in Hydrogen Peroxide-induced Apoptosis of a Human Glioblastoma Cell Line* , 1999, The Journal of Biological Chemistry.

[227]  K. Yahata,et al.  A unique talin homologue with a villin headpiece-like domain is required for multicellular morphogenesis in Dictyostelium , 1999, Current Biology.

[228]  D. Schlaepfer,et al.  Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.

[229]  Alan Hall,et al.  Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement , 1999, The Journal of cell biology.

[230]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[231]  Laura M. Machesky,et al.  Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex , 1998, Current Biology.

[232]  J. Guan,et al.  Regulation of the Cell Cycle by Focal Adhesion Kinase , 1998, The Journal of cell biology.

[233]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[234]  C. Damsky,et al.  Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.

[235]  M. Tang,et al.  Tyrosine Phosphorylation of Focal Adhesion Kinase Stimulated by Hepatocyte Growth Factor Leads to Mitogen-activated Protein Kinase Activation* , 1998, The Journal of Biological Chemistry.

[236]  J. Schwarzbauer,et al.  Control of Cell Cycle Progression by Fibronectin Matrix Architecture* , 1998, The Journal of Biological Chemistry.

[237]  S. Mizutani,et al.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. , 1998, Cancer research.

[238]  M. Ueno,et al.  A suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-induced apoptosis of T98G cells. , 1997, Biochemical and biophysical research communications.

[239]  J. Parsons,et al.  Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation , 1997, Molecular and cellular biology.

[240]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[241]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[242]  I. Zachary,et al.  Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[243]  T. Hunter,et al.  Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins , 1997, Molecular and cellular biology.

[244]  B. Ozanne,et al.  A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer , 1997, Oncogene.

[245]  J. Guan,et al.  Phosphorylation of Tyrosine 397 in Focal Adhesion Kinase Is Required for Binding Phosphatidylinositol 3-Kinase* , 1996, The Journal of Biological Chemistry.

[246]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[247]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[248]  L. Romer,et al.  Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. , 1996, Molecular biology of the cell.

[249]  K. Yokote,et al.  Phosphatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor. , 1996, Biochemical and biophysical research communications.

[250]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[251]  S. Hanks,et al.  Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[252]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[253]  C. Morimoto,et al.  Direct association of pp125FAK with paxillin, the focal adhesion- targeting mechanism of pp125FAK , 1995, The Journal of experimental medicine.

[254]  J. Parsons,et al.  Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.

[255]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[256]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[257]  S. Hanks,et al.  Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.

[258]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[259]  J. Guan,et al.  Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[260]  S. Hanks,et al.  Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[261]  S. Hanks,et al.  Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II , 1994, Journal of cellular biochemistry.

[262]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[263]  C. Turner,et al.  Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. , 1994, Molecular biology of the cell.

[264]  E. Rozengurt,et al.  Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. , 1994, The Journal of biological chemistry.

[265]  W. Cance,et al.  Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.

[266]  L. Cantley,et al.  Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts , 1993, Molecular and cellular biology.

[267]  C. Turner,et al.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly , 1992, The Journal of cell biology.

[268]  D. Shalloway,et al.  Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation , 1992, Nature.

[269]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[270]  A. Tonnel,et al.  Endothelial cells , 1991 .

[271]  J. Parsons,et al.  Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[272]  V. Golubovskaya.  Targeting FAK in human cancer: from finding to first clinical trials. , 2014, Frontiers in bioscience.

[273]  C. Steindler,et al.  TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. , 2008, Experimental cell research.

[274]  C. Steindler,et al.  TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling , 2008 .

[275]  V. Golubovskaya,et al.  Focal adhesion kinase and p53 signaling in cancer cells. , 2007, International review of cytology.

[276]  Y. Takata,et al.  Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways. , 2007, American journal of physiology. Cell physiology.

[277]  R. Madan,et al.  Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. , 2006, Human pathology.

[278]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.

[279]  J. Downward,et al.  Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.

[280]  J. Su,et al.  Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. , 2002, World journal of gastroenterology.